创新药相关ETF领涨，机构认为板块景气度可持续丨ETF基金日报

Market Overview - The Shanghai Composite Index fell by 0.44% to close at 3384.82 points, with a high of 3406.45 points [1] - The Shenzhen Component Index decreased by 0.86% to 10162.18 points, reaching a peak of 10256.85 points [1] - The ChiNext Index dropped by 1.17% to 2037.27 points, with a maximum of 2063.87 points [1] ETF Market Performance - The median return of stock ETFs was -0.67% [2] - The highest performing scale index ETF was Penghua CSI 800 Free Cash Flow ETF with a return of 0.39% [2] - The highest performing industry index ETF was China Merchants CSI Hong Kong-Shanghai 500 Pharmaceutical Health ETF with a return of 1.05% [2] - The highest performing strategy index ETF was China Fortune CSI All Share Free Cash Flow ETF with a return of 0.68% [2] - The highest performing style index ETF was China Merchants CSI Bank AH Price Preferred ETF with a return of 0.59% [2] - The highest performing theme index ETF was China Tai Bai Rui CSI Hong Kong-Shanghai Innovative Drug Industry ETF with a return of 1.61% [2] ETF Performance Rankings - The top three ETFs by return were: - Huatai-PB CSI Hong Kong-Shanghai Innovative Drug Industry ETF (1.61%) - Tibet Dongcai CSI Hong Kong-Shanghai Innovative Drug Industry ETF (1.41%) - GF Guozheng Grain Industry ETF (1.3%) [5] - The bottom three ETFs by return were: - Huatai-PB CSI Information Technology Application Innovation Industry ETF (-3.76%) - Huabao CSI Information Technology Application Innovation Industry ETF (-3.68%) - Huaxia CSI Information Technology Application Innovation Industry ETF (-3.21%) [6] ETF Fund Flows - The top three ETFs by fund inflow were: - Huaxia Shanghai Stock Exchange Sci-Tech Innovation Board 50 ETF (inflow of 645 million) - Fortune CSI Military Industry Leaders ETF (inflow of 309 million) - Guolian An CSI All Share Semiconductor Products and Equipment ETF (inflow of 255 million) [8] - The top three ETFs by fund outflow were: - Huatai-PB CSI 300 ETF (outflow of 1.1 billion) - Guotai Guozheng Information Technology Innovation Theme ETF (outflow of 704 million) - Huaxia CSI Information Technology Application Innovation Industry ETF (outflow of 644 million) [9] ETF Margin Trading Overview - The top three ETFs by margin buying were: - Huaxia Shanghai Stock Exchange Sci-Tech Innovation Board 50 ETF (buying amount of 648 million) - Guotai CSI All Share Securities Company ETF (buying amount of 224 million) - Huatai-PB CSI 300 ETF (buying amount of 210 million) [11] - The top three ETFs by margin selling were: - Huatai-PB CSI 300 ETF (selling amount of 20.71 million) - Huaxia CSI 1000 ETF (selling amount of 17.64 million) - Southern CSI 1000 ETF (selling amount of 13.50 million) [12] Institutional Insights - The innovation drug sector is expected to maintain its growth, driven by "innovation + internationalization" trends, with policy support and increasing global competitiveness [13] - The domestic market is anticipated to recover by 2025, with potential improvements in the medical service sector and AI healthcare innovations [13] - The pharmaceutical sector has shown strong performance recently, influenced by significant collaborations, and is recommended for increased allocation [14]